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Abstract Advanced glycation endproducts (AGEs) are sug-
gested to play an important role in diabetic nephropathy. They 
induce specific cellular responses such as the release of cytokines 
in different cell lines. The effect of AGEs on signal transduction 
pathways was investigated in the renal tubulus cell line LLC-
PKi. Using a serine-phosphate-specific antibody AGE-induced 
cellular responses associated with phosphorylation/dephospho-
rylation events were demonstrated. In particular, the p 4 2 M A P 
kinase and its downstream target, the AP-1 complex, are shown 
to be activated by AGE-BSA but not by BSA. In contrast, only 
partial phosphorylation is observed for the p70S6-kinase. Thus, 
AGEs appear to induce specific signal transduction pathways. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The amino groups of proteins react non-enzymatically with 
reducing monosaccharides, including glucose, fructose, hex-
ose-phosphates, trioses and triose-phosphates. This 'non-enzy-
matic glycosylation' or 'glycation' reaction leads through sub-
sequent oxidation, cyclisation and dehydration reactions to a 
broad range of heterogeneous fluorescent and yellow-brown, 
substances called 'Advanced Glycation Endproducts ' or 
'AGEs ' . A G E formation is irreversible and causes protease-
resistant cross-linking of long-lived peptides and proteins, 
leading to protein deposition and amyloidosis. Recent prog-
ress in the understanding of this process has confirmed that 
A G E s play a significant role in the pathogenesis of vascular 
complications in ageing and degenerative diseases, particularly 
in Alzheimer's disease, diabetes and end stage renal disease 
[1-3]. The pathological effects of AGEs were originally attrib-
uted to their physicochemical properties including protein 
cross-linking but more recent studies increasingly emphasise 
the role of A G E s in cellular signalling events by oxygen free 
radicals [4,5]. 
Among the cellular actions of AGEs , release of cytokines 
such as interleukin 1 and 6 and T N F - a has been described in 
different cell types such as macrophages, endothelial cells and 
even neurones [4,6]. These responses are most likely mediated 
by A G E receptors, among which the receptor for A G E s 
(RAGE) is the best studied member in term of signal trans-
duction [7]. Binding of A G E s to R A G E results in production 
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of superoxide radicals which subsequently activates transcrip-
tion factor N F - K - B , with consequences for a range of cellular 
functions [5]. However, intermediate signalling pathways from 
R A G E to the superoxide producing enzyme and the transcrip-
tional activation are yet to be identified. 
To demonstrate specific effects of A G E s on signal trans-
duction changes in the phosphorylation pattern of serine kin-
ases by A G E s as well as the effects on the p70S 6 -kinase and 
p42 M A P -kinase are shown in this study . 
The AGE-level in the serum is closely dependent on kidney 
function. On one hand circulating low molecular weight 
A G E s are eliminated by the kidney, on the other hand 
A G E s are suggested to be one of the major causes of diabetic 
nephropathy [8,9]. While A G E s have been shown to be in-
volved in glomerulosclerosis and to effect mesangial cells 
[9,10], little is known about effects of A G E s on the tubulus. 
Therefore a further objective of this study was to demonstrate 
that, in addition to the mesangial cells also tubular cells re-
spond to A G E s at the level of gene expression and signal 
transduction. 
2. Material and methods 
LLC-PKi renal epithelial cells (ATCC CRL 1392) were grown in 
Dulbecco's modified eagle medium (DMEM) supplemented with 10% 
foetal calf serum as described [11]. Cells were grown for 4 days until 
confluent monolayers were observed. Before treatment the cells were 
deprived for 24 h in DMEM containing 0.2% foetal calf serum. 
Bovine serum albumin (1 mM BSA Fraction V, Sigma) was gly-
cated by incubation with 1 M glucose in 50 mM potassium phosphate, 
pH 7.3, 1 mM EDTA under sterile conditions at 37°C for 40 days 
following a modified protocol of Makita et al. [26]. The AGE-BSA 
solution was lyophilized and extensively dialysed against bidestilled 
water. Residual glucose was less than 0.1 mM after this procedure. 
The preparation showed an E350 of 28 m M
H albumin. 
Western blots were performed as previously described [12]. Briefly, 
cells were lysed in 50 mM Tris-Cl, pH 6.7, 2% SDS, 2% mercapto-
ethanol, 1 mM sodium orthovanadate followed by digestion of nucleic 
acids with benzonase (Merck, Darmstadt, FRG). After SDS-PAGE 
(20 ug protein/well), proteins were transferred onto reinforced nitro-
cellulose by semidry blotting. The sheets were saturated with 2% BSA 
and incubated for 1 h with either mouse monoclonal antiphosphoser-
ine antibody clone 4A9 (1 ug/ml, Biomol, Germany), rabbit polyclo-
nal anti MAP-kinase (1 ug/ml, Santa Cruz, Germany) or rabbit poly-
clonal anti rat S6-kinase (1 ug/ml, Biomol, Germany) antibodies. 
After washing, sheep anti-mouse IgM horseradish peroxidase-labelled 
(1:10 000, Sigma) in case of antiphosphoserine or goat anti rabbit IgG 
horseradish peroxidase-labelled antibody (1:5000, Dianova) in case of 
the MAP and S6-kinase was added for 1 h. The detection was done by 
chemiluminescence, using luminol (2.5 mM) and p-coumaric acid (400 
uM) as enhancer. 
The electrophoretic mobility shift assay was mainly performed ac-
cording to the protocol of Lane et al. [13]. Nuclear cell extracts ol 
LLC PKi cells were prepared according to the protocol of Andrews 
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Fig. 1. AGEs inhibit proliferation of LLC-PKl cells. Proliferating 
LLC-PKl cells were treated with 50 uM AGE-BSA or 50 uM BSA. 
After 24 h, cell number and cell volume were determined with a 
Coulter-like cell counter (CASY-1 system). Results are means 
± S.E.M. of independent triplicate experiments. 
and Faller [14]. The AP-1 consensus sequence (CTAGAGCAT-
GAGTCAGACACT) was synthesised on a Gene-Assembler Plus 
(Pharmacia, Freiburg, Germany) and purified by preparative denatu-
rating gel electrophoresis. The oligonucleotide was labelled by filling 
the ends with Klenow polymerase (Boehringer Mannheim, Germany) 
according to manufacturer's instructions and subsequently purified 
from unincorporated nucleotides by gel filtration on Sephadex G-25 
(Pharmacia, Freiburg). Binding was performed in 10 mM HEPES, pH 
7.5, 0.5 mM EDTA, 50 mM KC1, 1 mM DTT, 5 mM spermidine, 
2 mM Ficoll 400, 6% glycerol, 1 mg/ml DNAse-free BSA, 0.2 mM 
benzamidine, 0.1 mM PMSF and 1 pM poly-dl/dC. To a total of 20 
ill 10 ug of nuclear extract and 1 ill of labelled oligonucleotide (0.1 
pMol with approximately 25000 cpm/|il) were added and incubated 
for 30 min at 4°C. Protein-DNA-Complexes were analysed by native 
polyacrylamide electrophoresis (5%) in 0.5XTBE and 5% glycerol. 
After drying the gel was exposed to a Kodak X-ray film overnight 
at —70°C using an intensifying screen. 
3. Results and discussion 
AGEs elicit a wide range of cell-mediated responses in dif-
ferent cell types which leads to a variety of effects, including 
anti-proliferative effects [15,16]. In the present study an anti-
proliferative effect was also observed in the tubulus cell line 
LLC-PKi. After incubation with 50 uM AGE modified BSA 
for 24 h AGE-BSA reduced significantly cell proliferation in 
comparison with control cells incubated with the same con-
centrations of BSA. In contrast there were neither significant 
changes in cell volume (Fig. 1) nor any significant cytotoxic 
effects to LLC-PKi cells (unpublished results), this is in ac-
cordance with observations of Chibber et al. [27]. In presence 
of non-modified BSA a slight increase of cell number could be 
observed (Fig. 1). This indicates that LLC-PKi cells respond 
to extracellular AGEs. In order to demonstrate whether these 
effects are receptor mediated, we looked for activation of fast 
signal transduction pathways by Western blot analysis. The 
influence of AGE modified BSA was measured on confluent 
monolayer cultures of serum deprived non-proliferating LLC-
PKi cells to avoid additional effects of serum. Under these 
conditions, cell number remained constant after 24 h treat-
ment with AGE-BSA. 
Initially overall phosphorylation of proteins was examined 
using a phospho-serine-specific monoclonal IgM antibody. 
Western blots of crude protein extracts of AGE-BSA and 
BSA-treated cells were probed with this antibody and signals 
were visualised by using the chemiluminescence detection 
method. After short-term exposure of the blot (few seconds), 
only one single band with a molecular weight of about 75 to 
80 kDa was visible (Fig. 2, upper panel). After prolonged 
exposure (5 min) many proteins carrying phospho-serine res-
idues became visible (Fig. 2, lower panel). The most promi-
nent effect is the dephosphorylation of a protein of about 100 
kDa (Fig. 2, lower panel, marked with an arrow) after treat-
ment with AGE-BSA, while this protein remains phosphoryl-
ated in cell extracts of BSA-treated cells. This result is in 
agreement with observations of Hasegawa and coworkers, 
who showed a marked decrease in tyrosine phosphorylation 
of paxillin and ppl25FAK after plating of endothelial cells on 
glycated basement matrix [17]. Our data show that fast phos-
phorylation/dephosphorylation events also occur in LLC-PKx 
cells upon administration of AGE-BSA indicating the involve-
ment of a signal transduction mechanism in the development 
of the observed effects on cell physiology. 
Subsequently we examined more specific effects of AGE-
BSA treatment by monitoring the activation of two major 
Fig. 2. AGEs induced serine phosphorylation/dephosphorylation. Serum deprived LLC-PKl cells were treated for the indicated times in min 
with 50 uM AGE-BSA or BSA. After lysis, the lysates (20 ug protein) were subjected to SDS-PAGE. Proteins were transferred onto nitrocellu-
lose and phosphoserine was detected by immuno-detection with antiphosphoserine antibody 4A9. Detection was done by chemiluminescence. 
Upper panel: short-term exposure (few seconds), lower panel: long-term exposure (min). 
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Fig. 3. AGEs activate the p42MAP-kinase. Quiescent LLC-PKl cells were treated with 50 |xM AGE-BSA or BSA for the indicated times. Ac-
cording to Fig. 2, the p42MAP kinase and the p70S6 kinase were detected by Western blotting. 
protein kinases, the p70S6 kinase and the p42MAP-kinase. 
These two kinases represent two different signal transduction 
pathways. 
The p70S6 kinase phosphorylates the 40S ribosomal protein 
S6, which is an important factor for cell growth after stimu-
lation with growth factors in mammalian cells [18,19]. The 
p70S6 kinase is located downstream of the PI3-kinase [20] 
and is activated by phosphorylation. Full activation of 
p70S6 kinase is achieved by multiple phosphorylations causing 
multiple band shifts in Western blots. However, AGE-BSA 
stimulates only a partial phosphorylation of p70S6 kinase 
(Fig. 3) since not all possible band shifts are visible. As only 
the completely phosphorylated form of p70S6 kinase can be 
correlated with an active kinase [21], AGE-BSA appears not 
to fully activate this kinase. In cell extracts of BSA-treated 
controls, no phosphorylation of p70S6 kinase was detectable 
by the band shift assay. Therefore, AGE-induced phosphoryl-
ation may enhance activation of p70S6 kinase in the presence 
of additional signals. 
The p2MAP-kinase (Erk) signalling cascade has been sug-
gested to act as a signal integration mechanism for many 
external signals in eucaryotic cells [22]. The p42MAP-kinase 
itself is activated by dual phosphorylation of conserved threo-
nine and tyrosine residues within a characteristic TEY motif 
via the ras and raf pathway. The active (phosphorylated) form 
migrated slower and is identified as a shifted band in Western 
blots using a MAP-kinase-specific antibody (Fig. 3). Whereas 
in Western blots of BSA-treated control cells no gel shift was 
observed, in extracts of cells incubated for 10 min with AGE-
BSA (50 (a.Mol) a band shift could be detected indicating 
phosphorylation of MAP-kinase (Fig. 3). After 60 min, the 
shifted band disappeared indicating dephosphorylation and 
inactivation of p42MAP-kinase. The time kinetic is similar to 
those observed after administration of growth factors to cells. 
These results indicate a direct or indirect stimulation of MAP-
kinase phosphorylation by AGEs pointing to a specific re-
sponse of LLC-PK4 cells to non-enzymatic endproducts. 
To further demonstrate activation of p42MAP kinase, we 
looked for downstream signals induced by this kinase. Acti-
vation of the AP-1 complex was chosen mainly for two rea-
sons. Firstly, induction of the transcription factor c-fos is one 
prominent and well characterised downstream effect of 
p42MAP-kinase activation [22]. Secondly, it has been reported 
that AGEs induce oxidative stress [6]. In addition to N F - K - B 
activation, AP-1 activation has been shown to occur in the 
course of response to stress, especially oxidative stress [23,24]. 
Indeed, in nuclear extracts of LLC-PKi cells after 30 min of 
incubation with artificial AGE-BSA an activation of the AP-1 
complex was detectable by the band shift assay when com-
pared with the controls, e.g. cells incubated with the same 
concentration of unmodified BSA (Fig. 4). The observed sig-
nal was completely inhibited by an excess of unlabelled AP-1 
oligonucleotide while the presence of excess SP-1 oligonucleo-
tide-binding sequence had no effect on the observed shift (Fig. 
4). Therefore, our results demonstrate that, as expected, treat-
ment with AGEs enhances AP-1 activation. This supports the 
hypothesis that phosphorylation of p42MAP kinase is of phys-
iological importance. 
Currently activation of transcription factors by advanced 
1 2 3 4 5 6 7 8 9 
Fig. 4. Demonstration of AGE induced AP-1 activity by gel shift 
analysis. Nuclear extracts of LLC-PKl incubated with 50 uM 
AGE-BSA (lanes 4, 5, 6) and BSA (lanes 1, 2, 3) for 30 min were 
prepared as described in Section 2 and analysed by gel shift assay 
using an AP-1 specific oligonucleotide. On lane 1, 2 and 3, 5 ug, 10 
ug and 15 ug of the nuclear extracts from BSA-treated cells were 
loaded, on lane 4, 5 and 6 the same amounts of nuclear extracts 
from AGE-BSA-treated cells were loaded. Lane 7 is without extract, 
lane 8 shows competition with an excess of unlabelled AP-1 oligo-
nucleotide, lane 9 is in presence of an excess of unlabelled SP-1 oli-
gonucleotide. 
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glycation endproducts has been reported for the major induc-
ible transcription factor in many immune and inflammatory 
processes, N F - K - B via the RAGE-receptor [6]. For many 
types of stress a co-activation of the NF-K-B complex and 
the activation protein (AP-1) was observed, al though the sig-
nal transduction pathways differ for both complexes [23,24]. 
Therefore it is reasonable to assume that following treatment 
with A G E s co-activation of AP-1 and N F - K - B can occur. In-
deed, the promoter region of the tissue factor gene, whose 
expression is induced by A G E s contains both NF-K-B and 
AP-1-binding sites [25]. 
In conclusion, our results confirm earlier observations that 
A G E s cause specific cellular response in different cell types. 
Fur thermore it is shown that the cellular response to A G E s is 
associated with phosphorylation/dephosphorylation events. 
The p42 M A P kinase was shown to be activated by AGE-BSA 
but not by BSA alone. The activation of the AP-1 complex 
supports the assumption that p42 M A P kinase is activated spe-
cifically. In contrast, only partial phosphorylation was ob-
served for the p70S6-kinase. The present results do not allow 
to demonstrate whether A G E s alone are capable of causing 
the observed effects directly or whether AGE-induced caused 
oxidative stress is responsible for the described cellular effects. 
Future work will be aimed at characterising the complete 
signal transduction pathway of AGEs . 
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